2026 NPPES data Vision Therapy Optometrist NPI 1477655751 O D
Verify on CMS →

JAMES CITEK, O D

Vision Therapy Optometrist in ANGLETON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
48
Medicare Part D claims · 23 beneficiaries · Vision Therapy Optometrist avg: 209
Generic prescribing
31%
generic claims · 69% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: JAMES CITEK, O D is a Vision Therapy Optometrist ([object Object]) practicing in ANGLETON, Texas with a Medicare Part D prescribing footprint of 48 claims across 23 beneficiaries — 69% brand-name prescribing .

What stands out: JAMES CITEK, O D filed 48 Medicare Part D claims in 2023 across ANGLETON, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JAMES CITEK, O D at a glance

Quality data not reported

NPI registry status

Active

Issued 09/05/2006

NPI 1477655751

Primary specialty

Vision Therapy Optometrist

Rare

369 US NPIs in this specialty

Medicare Part D claims

48 77% vs specialty avg

2023 prescription claims

Specialty avg: 209

Specialty distribution in Texas

How Vision Therapy Optometrist compares to other specialties among Texas providers

Texas providers

Vision Therapy Optometrist share within Texas

1. Vision Therapy Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Vision Therapy Optometrist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Vision Therapy Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Vision Therapy Optometrist ABMS/AOA estimate

Est. board-certified rate (Vision Therapy Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Vision Therapy Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAMES CITEK, O D is a Vision Therapy Optometrist provider practicing in ANGLETON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O D. NPI: 1477655751. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JAMES CITEK, O D appears in the CMS NPPES registry as a Vision Therapy Optometrist provider holding O D credentials at 1818 N VELASCO ST, ANGLETON, TX, 77515, with a listed phone of (979) 849-2331. NPI 1477655751 was issued on 09/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CITEK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 48 prescription claims written by this provider, covering 23 Medicare beneficiaries and totaling roughly $15K in drug spend, split 69% brand-name and 31% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Vision Therapy Optometrist is a narrow specialty nationwide, with 369 enrolled providers across 42 states and an average of 209 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1818 N VELASCO ST
ANGLETON, TX 77515

Provider Details

NPI 1477655751
Specialty Vision Therapy Optometrist
Credentials O D
Gender Male
NPI Issued 09/05/2006

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JAMES CITEK, O D. To verify JAMES CITEK, O D's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JAMES CITEK, O D — brand share 69.0%
Specialty average (est.)

69% brand-name claims vs 31% generic, on 48 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

48
Total Claims
$15K
Total Drug Cost
23
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
58
Total Day Supply
1,381
Brand vs Generic
69% brand / 31% generic
Brand Drug Cost
$15K
Generic Drug Cost
$138

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
0.77

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Lumigan
Bimatoprost
15
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Vision Therapy Optometrist Overview

How JAMES CITEK, O D fits within the Vision Therapy Optometrist landscape nationally.

369
Vision Therapy Optometrist Providers in US
42
States with Vision Therapy Optometrist
209
Avg Claims per Provider

JAMES CITEK, O D's 48 claims are below the specialty average of 209.

Nearby Vision Therapy Optometrist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as CITEK.

Compare Vision Therapy Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAMES CITEK, O D's specialty?
JAMES CITEK, O D specializes in Vision Therapy Optometrist and practices in ANGLETON, Texas. Credentials: O D.
How much does JAMES CITEK, O D prescribe under Medicare Part D?
In 2023, JAMES CITEK, O D wrote 48 Medicare Part D claims totaling $15K in drug costs for 23 beneficiaries.
Where is JAMES CITEK, O D located?
JAMES CITEK, O D is located at 1818 N VELASCO ST, ANGLETON, TX, 77515. Phone: (979) 849-2331.
What is JAMES CITEK, O D's NPI number?
JAMES CITEK, O D's National Provider Identifier (NPI) is 1477655751, issued on 09/05/2006.
Does JAMES CITEK, O D prescribe more brand-name or generic drugs?
JAMES CITEK, O D's prescribing is 69% brand-name and 31% generic drugs by claim count, with $15K in brand drug costs.
How many Vision Therapy Optometrist providers are there in the US?
There are 369 Vision Therapy Optometrist providers across 42 states in the US. The average Vision Therapy Optometrist provider writes 209 Medicare Part D claims per year.
What drugs does JAMES CITEK, O D prescribe most often?
Based on 2023 Medicare Part D data, JAMES CITEK, O D's most frequently prescribed drugs include Lumigan, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JAMES CITEK, O D accept Medicare?
JAMES CITEK, O D appears in CMS Medicare data with 48 Part D claims and 23 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAMES CITEK, O D's credentials?
JAMES CITEK, O D's NPI is 1477655751 with credentials O D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology